Toleranzia AB

Toleranzia AB

Pharmaceutical Manufacturing Goeteborg, Se 17 employees FIRST
Employees
17
Contacts
2
Emails
2

Toleranzia AB Overview

Headquarters
Goeteborg, Se
Phone Number
Available in AeroLeads
Website
toleranzia.com
Industry
Pharmaceutical Manufacturing
Employees
17
Founded
2011
Stock Symbol
FIRST
Funding
81.9K
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Toleranzia AB

Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. The company has a lead project in myasthenia gravis as well as a second project in ANCA vasculitis. Toleranzia is listed on the Nasdaq First North Growth Market and backed by strongly committed renowned specialist investors.

Toleranzia AB Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

Toleranzia AB Org Chart

Sample employees and titles
Name Title Contact
Vidar Wendel-Hansen
Email
Maarten Kraan
Email
Richard Christison Freelance Protein Expression Scientist : Sole Trader : Researcher : Consultant
View

Employees by Management Level

Individual contributor 4 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0

Toleranzia AB Tech Stack

Data / AI 3 profiles

Compare Similar Companies to Toleranzia AB